Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
276studies shown
Showing 169-180 of 276
Drug study icon
CompletedNCT00784654

Safety study of LDX in ADHD

This study is completed in the United States, in France, in the United Kingdom, .... It is testing LDX for ADHD.

In Belgium
ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Shire
Condition
ADHD
Other study type icon
CompletedNCT02700685

Effect of Pycnogenol® on ADHD

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In Belgium
ADHDOtherFrom 6 Years to 12 Years
Countries
Belgium
Sponsor
Nina Hermans
Condition
ADHD
Other study type icon
CompletedNCT00543088

Effectiveness of Anti-Psychotic in GPs Setting

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
Schizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Countries
Belgium
Sponsor
AstraZeneca
Condition
Schizophrenia, Bipolarity
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In Belgium
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01259492

Methylphenidate Hydrochloride Extended Release for ADHD

This study is completed in the United States, in Belgium, in Colombia, .... It is testing methylphenidate Hydrochloride Extended Release for ADHD.

In Belgium
ADHDDrugFrom 18 Years to 60 Years
Countries
United States, Belgium, Colombia, ...
Sponsor
Novartis Pharmaceuticals
Condition
ADHD
Drug study icon
CompletedEUCTR 2005-002388-95

Efficacy of agomelatine (25 to 50 mg/day) given orally on quality of remission in elderly depressed patients, after a 12-week treatment period.A flexible-dose internationa...

This study is completed in Belgium, in Hungary, in Denmark, .... It focuses on Depression.

In Belgium
DepressionOther
Countries
Belgium, Hungary, Denmark, ...
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Condition
Depression
Device study icon
CompletedNCT02095496

Efficacy of Closed-loop Ventilation to Reduced Sleep Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Belgium
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 94 Years
Countries
Belgium
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.